As of 2024-12-03, the Relative Valuation of West Pharmaceutical Services Inc (WST) is 305.97 USD. This relative valuation is based on P/E multiples. With the latest stock price at 325.68 USD, the upside of West Pharmaceutical Services Inc based on Relative Valuation is -6.1%.
The range of the Relative Valuation is 261.04 - 334.45 USD.
| Range | Selected | |
| Trailing P/E multiples | 37.8x - 48.5x | 43.3x |
| Forward P/E multiples | 32.7x - 38.2x | 36.1x |
| Fair Price | 261.04 - 334.45 | 305.97 |
| Upside | -19.8% - 2.7% | -6.1% |
| Date | P/E |
| 2024-11-29 | 47.21 |
| 2024-11-27 | 46.87 |
| 2024-11-26 | 46.29 |
| 2024-11-25 | 46.36 |
| 2024-11-22 | 45.89 |
| 2024-11-21 | 46.51 |
| 2024-11-20 | 45.18 |
| 2024-11-19 | 44.08 |
| 2024-11-18 | 44.53 |
| 2024-11-15 | 45.59 |
| 2024-11-14 | 49.01 |
| 2024-11-13 | 49.86 |
| 2024-11-12 | 47.50 |
| 2024-11-11 | 47.48 |
| 2024-11-08 | 46.98 |
| 2024-11-07 | 46.88 |
| 2024-11-06 | 47.75 |
| 2024-11-05 | 46.89 |
| 2024-11-04 | 45.63 |
| 2024-11-01 | 45.88 |
| 2024-10-31 | 44.64 |
| 2024-10-30 | 45.37 |
| 2024-10-29 | 46.16 |
| 2024-10-28 | 45.00 |
| 2024-10-25 | 44.63 |
| 2024-10-24 | 47.93 |
| 2024-10-23 | 41.52 |
| 2024-10-22 | 41.52 |
| 2024-10-21 | 41.64 |
| 2024-10-18 | 42.52 |
| 2024-10-17 | 41.84 |
| 2024-10-16 | 41.89 |
| 2024-10-15 | 42.19 |
| 2024-10-14 | 42.81 |
| 2024-10-11 | 42.75 |
| 2024-10-10 | 42.05 |
| 2024-10-09 | 41.53 |
| 2024-10-08 | 41.53 |
| 2024-10-07 | 42.10 |
| 2024-10-04 | 42.98 |
| 2024-10-03 | 43.10 |
| 2024-10-02 | 43.46 |
| 2024-10-01 | 43.46 |
| 2024-09-30 | 43.51 |
| 2024-09-27 | 45.08 |
| 2024-09-26 | 44.52 |
| 2024-09-25 | 43.97 |
| 2024-09-24 | 44.89 |
| 2024-09-23 | 44.46 |
| 2024-09-20 | 44.67 |